4.6 Review

Plasma Orexin-A Levels in Patients With Schizophrenia: A Systematic Review and Meta-Analysis

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Behavioral Sciences

Orexin deficiency modulates cognitive flexibility in a sex-dependent manner

Archana Durairaja et al.

Summary: Cognitive flexibility is a crucial executive function regulated by various neurotransmitter systems, with recent studies highlighting the role of the neuropeptide orexin in sex-specific modulation of cognitive flexibility.

GENES BRAIN AND BEHAVIOR (2021)

Article Neurosciences

Increased plasma orexin-A concentrations are associated with the non-motor symptoms in Parkinson's disease patients

Shen Huang et al.

Summary: The study found that plasma orexin-A levels were elevated in early-stage and medium-stage PD patients, but decreased in advanced-stage PD patients. Furthermore, orexin-A levels were correlated with non-motor symptoms in PD patients, such as insomnia, REM-sleep behavior disorder, anxiety, cognitive dysfunction, and autonomic nervous dysfunction.

NEUROSCIENCE LETTERS (2021)

Article Psychiatry

Changes of Hypocretin (Orexin) System in Schizophrenia: From Plasma to Brain

Jing Lu et al.

Summary: Research indicates decreased central hypocretin neurotransmission in schizophrenia patients, especially females. Plasma hypocretin-1 levels were significantly lower in schizophrenia patients, with female patients showing a more significant decrease. Hypothalamic hypocretin-1 ir also decreased in schizophrenia patients, primarily in females, while male patients showed changes in Hcrt-R mRNA expression.

SCHIZOPHRENIA BULLETIN (2021)

Review Neurosciences

The contribution of orexins to sex differences in the stress response

Laura A. Grafe et al.

BRAIN RESEARCH (2020)

Article Psychiatry

Orexin A in adolescents with anxiety disorders

Omer Faruk Akca et al.

INTERNATIONAL JOURNAL OF PSYCHIATRY IN CLINICAL PRACTICE (2020)

Article Clinical Neurology

Orexin-A Levels in Relation to the Risk of Metabolic Syndrome in Patients with Schizophrenia Taking Antipsychotics

Po-Yu Chen et al.

INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2019)

Article Multidisciplinary Sciences

HPLC analysis of CSF hypocretin-1 in type 1 and 2 narcolepsy

Noriaki Sakai et al.

SCIENTIFIC REPORTS (2019)

Letter Clinical Neurology

New revolution in the assessment of cerebrospinal fluid orexin-A: Enzyme-linked immunosorbent assay!

Claudio Liguori et al.

PSYCHIATRY AND CLINICAL NEUROSCIENCES (2019)

Article Clinical Neurology

Reduced plasma orexin-A levels in patients with bipolar disorder

Shoko Tsuchimine et al.

NEUROPSYCHIATRIC DISEASE AND TREATMENT (2019)

Review Biochemistry & Molecular Biology

Current Concepts and Treatments of Schizophrenia

Piotr Stepnicki et al.

MOLECULES (2018)

Review Cell Biology

The Orexin System and Hypertension

Michael J. Huber et al.

CELLULAR AND MOLECULAR NEUROBIOLOGY (2018)

Review Chemistry, Medicinal

Orexin research: patent news from 2016

Christoph Boss et al.

EXPERT OPINION ON THERAPEUTIC PATENTS (2017)

Review Biochemistry & Molecular Biology

New Targets for Schizophrenia Treatment beyond the Dopamine Hypothesis

Albert C. Yang et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2017)

Article Chemistry, Medicinal

Improving Current Treatments for Schizophrenia

Nadja P. Maric et al.

DRUG DEVELOPMENT RESEARCH (2016)

Article Endocrinology & Metabolism

Diurnal neurobiological alterations after exposure to clozapine in first-episode schizophrenia patients

Hong-Qiang Sun et al.

PSYCHONEUROENDOCRINOLOGY (2016)

Article Geriatrics & Gerontology

Changes in orexin (hypocretin) neuronal expression with normal aging in the human hypothalamus

Nicholas J. Hunt et al.

NEUROBIOLOGY OF AGING (2015)

Review Psychiatry

The Hypocretin System and Psychiatric Disorders

Fabio Pizza et al.

CURRENT PSYCHIATRY REPORTS (2014)

Review Biochemistry & Molecular Biology

Orexin: A potential role in the process of obstructive sleep apnea

Wei Wang et al.

PEPTIDES (2013)

Article Pharmacology & Pharmacy

Orexin-A and respiration in a rat model of smoke-induced chronic obstructive pulmonary disease

Zi-Bing Liu et al.

CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY (2010)

Article Multidisciplinary Sciences

The environment and schizophrenia

Jim van Os et al.

NATURE (2010)

Editorial Material Neurosciences

Orexin/hypocretin in psychiatric disorders: present state of knowledge and future potential

Stephanie L. Borgland et al.

NEUROPSYCHOPHARMACOLOGY (2010)

Article Psychiatry

Schizophrenia, hypocretin (Orexin), and the thalamocortical activating system

Evelyn K. Lambe et al.

SCHIZOPHRENIA BULLETIN (2007)

Article Psychiatry

The orexins/hypocretins and schizophrenia

Ariel Y. Deutch et al.

SCHIZOPHRENIA BULLETIN (2007)

Article Psychology, Clinical

A randomized, double-blind, placebo-controlled trial on modafinil for negative symptoms in schizophrenia

Joseph M. Pierre et al.

JOURNAL OF CLINICAL PSYCHIATRY (2007)

Review Medicine, General & Internal

A systematic review of the prevalence of schizophrenia

S Saha et al.

PLOS MEDICINE (2005)

Article Mathematical & Computational Biology

Controlling the risk of spurious findings from meta-regression

JPT Higgins et al.

STATISTICS IN MEDICINE (2004)

Article Medicine, General & Internal

Measuring inconsistency in meta-analyses

JPT Higgins et al.

BMJ-BRITISH MEDICAL JOURNAL (2003)

Article Nursing

Assessing publication bias in meta-analysis

KL Soeken et al.

NURSING RESEARCH (2003)

Article Endocrinology & Metabolism

Decreased plasma orexin-A levels in obese individuals

JA Adam et al.

INTERNATIONAL JOURNAL OF OBESITY (2002)

Article Psychiatry

Decreased dendritic spine density on prefrontal cortical pyramidal neurons in schizophrenia

LA Glantz et al.

ARCHIVES OF GENERAL PSYCHIATRY (2000)